Showing results (671-680 of 834) with videos related to
Sort By:
Pageof 84
British Journal of Haematology|May 17, 2018
Final results from a defibrotide treatment-IND study for patients with hepatic veno-occlusive disease/sinusoidal obstruction syndromeNancy A Kernan, Stephan Grupp, Angela R Smith, et al.Journal for Immunotherapy of Cancer|December 6, 2018
Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significanceMichael M Boyiadzis, Madhav V Dhodapkar, Renier J Brentjens, et al.Blood|September 23, 2017
Cellular kinetics of CTL019 in relapsed/refractory B-cell acute lymphoblastic leukemia and chronic lymphocytic leukemiaKaren Thudium Mueller, Shannon L Maude, David L Porter, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 13, 2017
Defibrotide for Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome: Interim Results from a Treatment IND StudyPaul G Richardson, Angela R Smith, Brandon M Triplett, et al.JAMA Network Open|November 11, 2024
Race, Neighborhood Disadvantage, and Prehospital Law Enforcement Handcuffing in Children With Behavioral Health EmergenciesKenshata Watkins, Nicolaus W Glomb, Tarak K Trivedi, et al.Pediatric Emergency Care|March 21, 2019
Adolescent Substance Abuse Risk: A Comparison of Pediatric Emergency Care Applied Research Network Emergency Department Patients and 2 Nationally Representative SamplesThomas H Chun, Lauren S Chernick, Fahd A Ahmad, et al.Experimental and Molecular Pathology|August 17, 2013
Reduced CD147 expression is linked to ERG fusion-positive prostate cancers but lacks substantial impact on PSA recurrence in patients treated by radical prostatectomyKatharina Grupp, Thorsten Simon Höhne, Kristina Prien, et al.The Lancet. Haematology|September 24, 2021
CD19-targeted chimeric antigen receptor T-cell therapy for CNS relapsed or refractory acute lymphocytic leukaemia: a post-hoc analysis of pooled data from five clinical trialsAllison Barz Leahy, Haley Newman, Yimei Li, et al.BMC Cancer|November 14, 2018
Reduced RBM3 expression is associated with aggressive tumor features in esophageal cancer but not significantly linked to patient outcomeKatharina Grupp, Bianca Hofmann, Asad Kutup, et al.Blood|May 17, 2013
Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapyDavid T Teachey, Susan R Rheingold, Shannon L Maude, et al.Pageof 84